Characteristic | Total number | No. patients, stratified by CDK5 | Z | P value | |
---|---|---|---|---|---|
Negative (228) | Positive (266) | ||||
Age |  |  |  | −1.557 | 0.120a |
 ≤44 | 263 | 130 (49.4 %) | 133 (50.6 %) |  |  |
 >44 | 231 | 98 (42.4 %) | 133 (57.6 %) |  |  |
Lymph node metastasis |  |  |  | −5.998 | <0.001a |
 Negative | 264 | 128 (48.5 %) | 136 (51.5 %) |  |  |
 Positive | 96 | 13 (13.5 %) | 83 (86.5 %) |  |  |
Histological type | Â | Â | Â | 32.490 | <0.001b |
 Chronic cervicitis | 54 | 39 (72.2 %) | 15 (27.8 %) |  |  |
 CA | 42 | 29 (69.0 %) | 13 (31.0 %) |  |  |
 Carcinoma in situ | 38 | 19 (50.0 %) | 19 (50.0 %) |  |  |
 Adenocarcinoma | 63 | 29 (46.0 %) | 34 (54.0 %) |  |  |
 SCC | 263 | 98 (37.3 %) | 165 (62.7 %) |  |  |
 Adenosquamous carcinoma | 34 | 14 (41.2 %) | 20 (58.8 %) |  |  |
FIGO stage |  |  |  | −5.998 | <0.001a |
 I–II | 264 | 128 (48.5 %) | 136 (51.5 %) |  |  |
 III–IV | 96 | 13 (13.5 %) | 83 (86.5 %) |  |  |
TNM stage | Â | Â | Â | 52.911 | <0.001b |
 0 | 38 | 19 (50.0 %) | 19 (50.0 %) |  |  |
 I | 248 | 128 (51.6 %) | 120 (48.4 %) |  |  |
 II–IV | 112 | 13 (11.6 %) | 99 (88.4 %) |  |  |
Pathological grade | Â | Â | Â | 23.604 | <0.001b |
 I | 28 | 16 (57.1 %) | 12 (42.9 %) |  |  |
 II | 157 | 77 (49.0 %) | 80 (51.0 %) |  |  |
 III | 141 | 34 (24.1 %) | 107 (75.9 %) |  |  |